US Stock MarketDetailed Quotes

Matinas BioPharma (MTNB)

Watchlist
  • 0.5610
  • -0.0111-1.94%
Close May 15 16:00 ET
3.59MMarket Cap-0.28P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Matinas BioPharma (MTNB) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
20.23%-1.6M
55.86%-7.01M
57.01%-1.51M
57.89%-1.47M
34.93%-2.02M
65.21%-2.01M
-3.97%-15.89M
23.35%-3.51M
20.80%-3.5M
-41.63%-3.11M
Net income from continuing operations
-16.00%-1.92M
57.34%-10.35M
77.33%-1.91M
64.16%-1.53M
8.29%-5.25M
71.57%-1.66M
-5.71%-24.25M
-58.69%-8.43M
29.40%-4.28M
5.63%-5.72M
Operating gains losses
----
--3.37M
--314K
--0
--3.35M
---294K
----
----
----
----
Depreciation and amortization
-42.19%74K
-53.09%456K
-61.54%95K
-38.82%331K
-75.00%-98K
-46.67%128K
3.29%972K
2.92%247K
127.31%541K
-123.93%-56K
Deferred tax
----
--0
----
----
----
----
---84K
----
----
----
Other non cash items
----
----
----
----
----
----
-115.89%-17K
-105.88%-1K
-1,829.41%-294K
796.55%260K
Change In working capital
126.60%133K
-1,052.67%-1.51M
-359.30%-223K
29.98%-306K
-133.92%-481K
58.26%-500K
-107.86%-131K
110.82%86K
-336.22%-437K
-40.82%1.42M
-Change in prepaid assets
-386.55%-341K
13.29%665K
155.95%141K
720.00%205K
-83.43%200K
130.28%119K
-85.26%587K
-1,838.46%-252K
108.74%25K
-35.18%1.21M
-Change in payables and accrued expense
245.23%639K
-1,698.41%-1.13M
-76.56%120K
-7.85%-316K
-234.69%-497K
32.41%-440K
96.41%-63K
181.14%512K
-147.56%-293K
-44.76%369K
-Change in other current liabilities
7.82%-165K
-59.08%-1.04M
-178.16%-484K
-15.38%-195K
-16.46%-184K
-16.23%-179K
-16.55%-655K
-15.23%-174K
-16.55%-169K
-17.91%-158K
Cash from discontinued investing activities
Operating cash flow
20.23%-1.6M
55.86%-7.01M
57.01%-1.51M
57.89%-1.47M
34.93%-2.02M
65.21%-2.01M
-3.97%-15.89M
23.35%-3.51M
20.80%-3.5M
-41.63%-3.11M
Investing cash flow
Cash flow from continuing investing activities
-96.36%335K
-97.00%15K
-96.68%320K
0
0
-30.46%9.21M
-83.11%500K
789.85%9.65M
-147.40%-2.94M
Net PPE purchase and sale
----
----
----
----
----
----
--0
--0
--0
----
Net investment purchase and sale
----
--0
--0
--0
--0
--0
-31.59%9.21M
-83.11%500K
776.91%9.65M
-145.91%-2.94M
Net other investing changes
----
--335K
--15K
----
----
----
----
----
----
----
Cash from discontinued investing activities
Investing cash flow
--0
-96.36%335K
-97.00%15K
-96.68%320K
--0
--0
-30.46%9.21M
-83.11%500K
789.85%9.65M
-147.40%-2.94M
Financing cash flow
Cash flow from continuing financing activities
0
-63.04%3.39M
5,900.00%58K
195.52%64K
-82.35%1.62M
3,007.55%1.65M
131,157.14%9.17M
0.00%-1K
-6,600.00%-67K
919,000.00%9.19M
Net issuance payments of debt
--0
-80.00%-9K
-600.00%-7K
--0
0.00%-1K
0.00%-1K
28.57%-5K
0.00%-1K
-100.00%-2K
0.00%-1K
Net common stock issuance
----
--0
--0
--0
--0
--0
--9.18M
--0
---65K
--9.19M
Net preferred stock issuance
--0
--3.3M
--0
--0
--1.65M
--1.65M
--0
--0
--0
--0
Proceeds from stock option exercised by employees
----
--129K
--65K
----
----
----
--0
--0
----
----
Net other financing activities
----
---29K
--0
--0
---27K
---2K
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
--0
-63.04%3.39M
5,900.00%58K
195.52%64K
-82.35%1.62M
3,007.55%1.65M
131,157.14%9.17M
0.00%-1K
-6,600.00%-67K
919,000.00%9.19M
Net cash flow
Beginning cash position
-43.60%4.25M
49.57%7.53M
-46.09%5.69M
51.70%6.78M
443.07%7.17M
49.57%7.53M
-28.86%5.04M
58.40%10.55M
-55.31%4.47M
-77.94%1.32M
Current changes in cash
-344.72%-1.6M
-231.56%-3.29M
52.31%-1.44M
-117.93%-1.09M
-112.69%-399K
90.31%-360K
222.22%2.5M
-85.86%-3.01M
282.22%6.08M
-21.45%3.15M
End cash Position
-63.09%2.65M
-43.60%4.25M
-43.60%4.25M
-46.09%5.69M
51.70%6.78M
443.07%7.17M
49.57%7.53M
49.57%7.53M
58.40%10.55M
-55.31%4.47M
Free cash flow
20.23%-1.6M
55.86%-7.01M
57.01%-1.51M
57.89%-1.47M
34.93%-2.02M
65.21%-2.01M
-2.51%-15.89M
23.35%-3.51M
21.08%-3.5M
-29.69%-3.11M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 20.23%-1.6M55.86%-7.01M57.01%-1.51M57.89%-1.47M34.93%-2.02M65.21%-2.01M-3.97%-15.89M23.35%-3.51M20.80%-3.5M-41.63%-3.11M
Net income from continuing operations -16.00%-1.92M57.34%-10.35M77.33%-1.91M64.16%-1.53M8.29%-5.25M71.57%-1.66M-5.71%-24.25M-58.69%-8.43M29.40%-4.28M5.63%-5.72M
Operating gains losses ------3.37M--314K--0--3.35M---294K----------------
Depreciation and amortization -42.19%74K-53.09%456K-61.54%95K-38.82%331K-75.00%-98K-46.67%128K3.29%972K2.92%247K127.31%541K-123.93%-56K
Deferred tax ------0-------------------84K------------
Other non cash items -------------------------115.89%-17K-105.88%-1K-1,829.41%-294K796.55%260K
Change In working capital 126.60%133K-1,052.67%-1.51M-359.30%-223K29.98%-306K-133.92%-481K58.26%-500K-107.86%-131K110.82%86K-336.22%-437K-40.82%1.42M
-Change in prepaid assets -386.55%-341K13.29%665K155.95%141K720.00%205K-83.43%200K130.28%119K-85.26%587K-1,838.46%-252K108.74%25K-35.18%1.21M
-Change in payables and accrued expense 245.23%639K-1,698.41%-1.13M-76.56%120K-7.85%-316K-234.69%-497K32.41%-440K96.41%-63K181.14%512K-147.56%-293K-44.76%369K
-Change in other current liabilities 7.82%-165K-59.08%-1.04M-178.16%-484K-15.38%-195K-16.46%-184K-16.23%-179K-16.55%-655K-15.23%-174K-16.55%-169K-17.91%-158K
Cash from discontinued investing activities
Operating cash flow 20.23%-1.6M55.86%-7.01M57.01%-1.51M57.89%-1.47M34.93%-2.02M65.21%-2.01M-3.97%-15.89M23.35%-3.51M20.80%-3.5M-41.63%-3.11M
Investing cash flow
Cash flow from continuing investing activities -96.36%335K-97.00%15K-96.68%320K00-30.46%9.21M-83.11%500K789.85%9.65M-147.40%-2.94M
Net PPE purchase and sale --------------------------0--0--0----
Net investment purchase and sale ------0--0--0--0--0-31.59%9.21M-83.11%500K776.91%9.65M-145.91%-2.94M
Net other investing changes ------335K--15K----------------------------
Cash from discontinued investing activities
Investing cash flow --0-96.36%335K-97.00%15K-96.68%320K--0--0-30.46%9.21M-83.11%500K789.85%9.65M-147.40%-2.94M
Financing cash flow
Cash flow from continuing financing activities 0-63.04%3.39M5,900.00%58K195.52%64K-82.35%1.62M3,007.55%1.65M131,157.14%9.17M0.00%-1K-6,600.00%-67K919,000.00%9.19M
Net issuance payments of debt --0-80.00%-9K-600.00%-7K--00.00%-1K0.00%-1K28.57%-5K0.00%-1K-100.00%-2K0.00%-1K
Net common stock issuance ------0--0--0--0--0--9.18M--0---65K--9.19M
Net preferred stock issuance --0--3.3M--0--0--1.65M--1.65M--0--0--0--0
Proceeds from stock option exercised by employees ------129K--65K--------------0--0--------
Net other financing activities -------29K--0--0---27K---2K----------------
Cash from discontinued financing activities
Financing cash flow --0-63.04%3.39M5,900.00%58K195.52%64K-82.35%1.62M3,007.55%1.65M131,157.14%9.17M0.00%-1K-6,600.00%-67K919,000.00%9.19M
Net cash flow
Beginning cash position -43.60%4.25M49.57%7.53M-46.09%5.69M51.70%6.78M443.07%7.17M49.57%7.53M-28.86%5.04M58.40%10.55M-55.31%4.47M-77.94%1.32M
Current changes in cash -344.72%-1.6M-231.56%-3.29M52.31%-1.44M-117.93%-1.09M-112.69%-399K90.31%-360K222.22%2.5M-85.86%-3.01M282.22%6.08M-21.45%3.15M
End cash Position -63.09%2.65M-43.60%4.25M-43.60%4.25M-46.09%5.69M51.70%6.78M443.07%7.17M49.57%7.53M49.57%7.53M58.40%10.55M-55.31%4.47M
Free cash flow 20.23%-1.6M55.86%-7.01M57.01%-1.51M57.89%-1.47M34.93%-2.02M65.21%-2.01M-2.51%-15.89M23.35%-3.51M21.08%-3.5M-29.69%-3.11M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +34.01%
Sample Name
Sample Code
 +27.74%
Sample Name
Sample Code
 +26.87%
4
United States Gasoline Fund Lp
UGA
+26.33%
5
Powershares Db Multi-Sector Commodi Powershares Db Oil Fund
DBO
+20.91%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +11.54%
Sample Name
Sample Code
 +10.70%
Sample Name
Sample Code
 +6.24%
4
NIO Inc
NIO
+4.27%
5
Hesai
HSAI
+3.89%
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -